An incredible story that also shows we have a director who actually listens to retail shareholders, and acts on that information.
It's a great outcome but also a compelling data point against those who would say you spend too much time talking with retail shareholders across various platforms. You are here because you value what we have to say.
Btw, converted my bonus options today - thanks. What a week we have had! Onwards and upwards, go Race!
Ann: Professor Erin Howden Joins Race Oncology SAB, page-17
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
